GenoDx
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $350M
Overview
A precision oncology diagnostics firm using AI-powered genomic analysis to guide personalized cancer therapy.
Oncology
Technology Platform
An integrated diagnostic platform combining next-generation sequencing with proprietary AI-driven bioinformatics software for variant interpretation and clinical reporting.
Funding History
1Total raised:$350M
Series B$350M
Opportunities
Expansion into liquid biopsy and MRD testing represents a significant growth avenue in cancer monitoring.
Risk Factors
Reimbursement challenges and rapid technological obsolescence in sequencing are persistent risks.
Competitive Landscape
Faces competition from large reference laboratories like Foundation Medicine and Quest Diagnostics, as well as in-house hospital lab developments.